Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

• Publication date: November 2011

Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Summary GlobalData’s new report, “Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis ...

Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Summary

GlobalData’s new report, “Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators market. The report provides market landscape, competitive landscape and market trends information on the implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include Cardiac Resynchronisation Therapy - Defibrillators, Dual Chamber Implantable Cardioverter Defibrillators and Single Chamber Implantable Cardioverter Defibrillators.
- Annualized market revenues data from 2003 to 2010, forecast forward for 7 years to 2017. Company shares data for 2010.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within the implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Medtronic, Boston Scientific, St. Jude Medical, BIOTRONIK and Sorin Group.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next big thing in the implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators market and the factors shaping it.

Global Cardiovascular Devices Industry

1 Table of Contents
1 Table of Contents 1
1.1 List of Tables 5
1.2 List of Figures 7
2 Executive Summary 8
2.1 The Global Implantable Cardioverter Defibrillators (ICD) and Cardiac Resynchronization Therapy-Defibrillators (CRT-D) Market is Forecast to Grow at a Rate of 5% Over the Period 2010–2017 8
2.2 Medtronic Dominates the Global ICD and CRT-D Market with a Share of More Than 40% 9
2.3 Increasing Patient Pool and Better Adoption Rates of ICD and CRT-D for Treatment of Cardiac Arrhythmias and Heart Failures to Drive Market Growth 9
2.4 The US is the Largest Market for ICD and CRT-D Devices Contributing about 56% of the Global Revenue in 2010 10
3 Introduction 11
3.1 GlobalData Report Guidance 11
4 Disease Overview - Arrhythmia 12
4.1 Types of Arrhythmia 12
4.2 Symptoms 13
5 Device Overview 14
5.1 Implantable Cardioverter Defibrillator (ICD) 14
5.1.1 Dual Chamber Implantable Cardioverter Defibrillator 14
5.1.2 Single Chamber Implantable Cardioverter Defibrillator 14
5.2 Cardio Resynchronization Therapy Defibrillators 14
6 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Market Characterization 15
6.1 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators Market, Global, Revenue ($bn), Historic, 2003-2010 15
6.2 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators Market, Global, Revenue ($bn), Forecast, 2010-2017 16
6.3 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators, Key Technology Trends 17
6.3.1 Percutaneous Implantable ICDs 17
6.3.2 Subcutaneous ICDs 17
6.3.3 Automatic Diagnosis 17
6.4 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators, Market Dynamics 17
6.4.1 Market Drivers 17
6.4.2 Market Restraints 22
7 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, by Country, Revenue, 2003 - 2017 24
7.1 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, the US, Revenue ($bn), Historic, 2003-2010 24
7.2 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, the US, Revenue ($bn), Forecast, 2010-2017 25
7.3 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Canada, Revenue ($m), Historic, 2003 - 2010 26
7.4 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Canada, Revenue ($m), Forecast, 2010 - 2017 27
7.5 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, the UK, Revenue ($m), Historic, 2003 - 2010 28
7.6 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, the UK, Revenue ($m), Forecast, 2010 - 2017 29
7.7 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Germany, Revenue ($m), Historic, 2003 - 2010 30
7.8 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Germany, Revenue ($m), Forecast, 2010 - 2017 31
7.9 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, France, Revenue ($m), Historic, 2003 - 2010 32
7.10 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, France, Revenue ($m), Forecast, 2010 - 2017 33
7.11 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Italy, Revenue ($m), Historic, 2003 - 2010 34
7.12 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Italy, Revenue ($m), Forecast, 2010-2017 35
7.13 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Spain, Revenue ($m), Historic, 2003 - 2010 36
7.14 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Spain, Revenue ($m), Forecast, 2010 - 2017 37
7.15 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Japan, Revenue ($m), Historic, 2003 - 2010 38
7.16 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Japan, Revenue ($m), Forecast, 2010 - 2017 39
7.17 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, China, Revenue ($m), Historic, 2003 - 2010 40
7.18 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, China, Revenue ($m), Forecast, 2010-2017 41
7.19 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, India, Revenue ($m), Historic, 2003 - 2010 42
7.20 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, India, Revenue ($m), Forecast, 2010 - 2017 43
7.21 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Australia, Revenue ($m), Historic, 2003 - 2010 44
7.22 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Australia, Revenue ($m), Forecast, 2010 - 2017 45
7.23 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillator Market, Brazil, Revenue ($m), Historic, 2003 - 2010 46
7.24 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Brazil, Revenue ($m), Forecast, 2010 - 2017 47
8 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators Market - Strategic Competitive Assessment 48
8.1 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators, Global, Company Share (%), 2010 48
8.2 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators, Opportunities and Threats 49
8.2.1 Opportunities 49
8.2.2 Threats 49
8.3 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators, Key Market Participants 50
8.3.1 Medtronic, Inc 50
8.3.2 St Jude Medical, Inc 51
8.3.3 Boston Scientific Corporation 52
8.3.4 Biotronik 53
8.3.5 Sorin Group 54
9 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Key Marketed Products 55
9.1 Protecta XT DR/VR and Protecta DR/VR ICDs 55
9.1.1 Product Description 55
9.1.2 Features and Benefits 55
9.2 Secura DR/VR ICDs 55
9.2.1 Product Description 55
9.2.2 Features and Benefits 55
9.3 Protecta XT and Protecta CRT-Ds 55
9.3.1 Product Description 55
9.3.2 Features and Benefits 55
9.4 Consulta CRT-Ds 56
9.4.1 Product Description 56
9.4.2 Features and Benefits 56
9.5 Maximo II CRT-Ds 56
9.5.1 Product Description 56
9.6 AnalyST Accel ICDs 56
9.6.1 Product Description 56
9.6.2 Features and Benefits 56
9.7 Atlas and Atlas II ICDs 57
9.7.1 Product Description 57
9.7.2 Features and Benefits 57
9.8 Current Accel DR/VR ICDs 57
9.8.1 Product Description 57
9.8.2 Features and Benefits 57
9.9 Current RF ICDs 57
9.9.1 Product Description 57
9.9.2 Features and Benefits 57
9.10 Epic and Epic II ICDs 58
9.10.1 Product Description 58
9.10.2 Features and Benefits 58
9.11 Epic HF CRT-Ds 58
9.11.1 Product Description 58
9.11.2 Features and Benefits 58
9.12 Fortify and Fortify ST ICDs 58
9.12.1 Product Description 58
9.12.2 Features and Benefits 58
9.13 PROMOTE CRT-Ds 59
9.13.1 Product Description 59
9.13.2 Features and Benefits 59
9.14 TELIGEN ICDs 59
9.14.1 Product Description 59
9.14.2 Features and Benefits 59
9.15 CONFIENT ICDs 60
9.15.1 Product Description 60
9.15.2 Features and Benefits 60
9.16 VITALITY ICDs 60
9.16.1 Product Description 60
9.17 COGNIS CRT-Ds 60
9.17.1 Product Description 60
9.17.2 Features and Benefits 60
9.18 CONTAK RENEWAL Series CRT-Ds 61
9.18.1 Product Description 61
9.18.2 Features and Benefits 61
9.19 LIVIAN CRT-Ds 61
9.19.1 Product Description 61
9.19.2 Features and Benefits 61
9.20 Lumax 540 series ICDs and CRT-Ds 62
9.20.1 Product Description 62
9.20.2 Features and Benefits 62
9.21 Lumax 300/340 VR-T (XL)/DR-T ICD and CRT-Ds 62
9.21.1 Product Description 62
9.21.2 Features and Benefits 62
9.22 Ovatio CRT-D 62
9.22.1 Product Description 62
9.22.2 Features and Benefits 62
9.23 Paradym Family of ICDs 63
9.23.1 Product Description 63
9.23.2 Features and Benefits 63
9.24 Paradym CRT-D 63
9.24.1 Product Description 63
9.24.2 Features and Benefits 63
10 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Pipeline Assessment 64
10.1 Implantable Cardioverter Defibrillators, Pipeline Products 64
10.1.1 AnalyST ACCEL ICD 65
10.1.2 AnalyST ICD 65
10.1.3 CardiaLen ICD 66
10.1.4 Chronicle ICD 66
10.1.5 Current Plus ICD 68
10.1.6 ENERGEN ICD 69
10.1.7 FORTIFY ST ICD 69
10.1.8 INCEPTA ICD 70
10.1.9 Paradym DR ICD 70
10.1.10 Paradym VR Model 8250 ICD 71
10.1.11 PUNCTUA ICD 71
10.1.12 S-ICD 72
10.1.13 Unconditional MRI Compatible ICD 73
10.2 Cardiac Resynchronization Therapy-Defibrillators, Pipeline Products 74
10.2.1 ENERGEN CRT-D 75
10.2.2 INCEPTA CRT-D 75
10.2.3 Next Generation Quad Polar CRT- D 76
10.2.4 Paradym RF 8770 SonR CRT-D 76
10.2.5 Clinical Trials 77
10.2.6 Paradym RF CRT-D 77
10.2.7 Platinium ICD - CRT-D 78
10.2.8 Promote Quadra CRT- D 78
10.2.9 PUNCTUA CRT-D 80
10.2.10 Unify Quadra CRT-D 80
11 Implantable Cardioverter Defibrillators and CardiacResynchronization Therapy Defibrillator Market - Deals Landscape 81
11.1 Boston Scientific Corporation Completes Acquisition of Atritech 81
11.2 Boston Scientific Corporation Enters into an Agreement with Fukuda Denshi 81
11.3 St. Jude Medical Enters into an Agreement with iRhythm Technologies 82
11.4 CLT Forms Joint Venture Company with Erasmus 82
11.5 AorTech International Expands Licensing Agreement with St. Jude Medical 82
12 Appendix 83
12.1 Definitions 84
12.1.1 Cardiac Resynchronization Therapy - Defibrillator 84
12.1.2 Implantable Cardioverter Defibrillator 84
12.1.3 Dual Chamber Implantable Cardioverter Defibrillator 84
12.1.4 Single Chamber Implantable Cardioverter Defibrillator 84
12.2 Acronyms 84
12.3 Research Methodology 86
12.4 Secondary Research 87
12.5 Primary Research 87
12.6 Models 87
12.7 Forecasts 88
12.8 Expert Panels 88
12.9 GlobalData Consulting 88
12.10 Contact Us 88
12.11 Disclaimer 88
12.12 Sources 89

List of Tables

Table 1: Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators Market, Global, Revenue ($bn), 2003-2010 15
Table 2: Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators Market, Global, Revenue ($bn), 2010-2017 16
Table 3: Technological Innovations, Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators 18
Table 4: Landmark Clinical Trials for Implantable Cardioverter Defibrillators 19
Table 5: Landmark Clinical Trials for Cardiac Resynchronization Therapy-Defibrillators 20
Table 6: Cardiac Rhythm Management Market, List of Device Recalls, 2004-2010 22
Table 7: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, the US, Revenue ($bn), 2003-2010 24
Table 8: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, the US, Revenue ($bn), 2010-2017 25
Table 9: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Canada, Revenue ($m), 2003-2010 26
Table 10: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Canada, Revenue ($m), 2010-2017 27
Table 11: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, the UK, Revenue ($m), 2003-2010 28
Table 12: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, the UK, Revenue ($m), 2010-2017 29
Table 13: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Germany, Revenue ($m), 2003-2010 30
Table 14: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Germany, Revenue ($m), 2010-2017 31
Table 15: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, France, Revenue ($m), 2003-2010 32
Table 16: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, France, Revenue ($m), 2010-2017 33
Table 17: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Italy, Revenue ($m), 2003-2010 34
Table 18: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Italy, Revenue ($m), 2010-2017 35
Table 19: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Spain, Revenue ($m), 2003-2010 36
Table 20: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Spain, Revenue ($m), 2010-2017 37
Table 21: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Japan, Revenue ($m), 2003-2010 38
Table 22: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Japan, Revenue ($m), 2010-2017 39
Table 23: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, China, Revenue ($m), 2003-2010 40
Table 24: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, China, Revenue ($m), 2010-2017 41
Table 25: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, India, Revenue ($m), 2003-2010 42
Table 26: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, India, Revenue ($m), 2010-2017 43
Table 27: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Australia, Revenue ($m), 2003-2010 44
Table 28: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Australia, Revenue ($m), 2010-2017 45
Table 29: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Brazil, Revenue ($m), 2003-2010 46
Table 30: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Brazil, Revenue ($m), 2010-2017 47
Table 31: Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators Market, Global, Company Share (%), 2010 48
Table 32: Protecta XT DR/VR and Protecta DR/VR, Features and Benefits 55
Table 33: Secura DR/VR; Features and Benefits 55
Table 34: Protecta XT and Protecta CRT-Ds, Features and Benefits 55
Table 35: Consulta CRT-D; Features and Benefits 56
Table 36: Maximo II CRT-D, Features and Benefits 56
Table 37: AnalyST Accel ICD; Features and Benefits 56
Table 38: Atlas ICDs; Features and Benefits 57
Table 39: Current Accel DR/VR ICD; Features and Benefits 57
Table 40: Current RF ICD; Features and Benefits 57
Table 41: Epic ICDs; Features and Benefits 58
Table 42: Epic HF CRT-Ds, Features and Benefits 58
Table 43:Fortify and Fortify ST ICD; Features and Benefits 58
Table 44: PROMOTE CRT-Ds; Features and Benefits 59
Table 45: TELIGEN ICDs; Features and Benefits 59
Table 46: CONFIENT ICDs; Features and Benefits 60
Table 47: VITALITY ICDs; Features and Benefits 60
Table 48: COGNIS CRT-Ds, Features and Benefits 60
Table 49: CONTAK RENEWAL Series CRT-Ds, Features and Benefits 61
Table 50: LIVIAN CRT-Ds, Features and Benefits 61
Table 51: Lumax 540 series ICDs and CRT-Ds, Features and Benefits 62
Table 52: Lumax 300/340 VR-T (XL)/DR-T ICD, Features and Benefits 62
Table 53: Ovatio CRT-D, Features and Benefits 62
Table 54: Paradym Family of ICDs, Features and Benefits 63
Table 55: Paradym CRT-D, Features and Benefits 63
Table 56: Implantable Cardioverter Defibrillators, Pipeline Products, 2011 64
Table 57: Implantable Cardioverter Defibrillators, AnalyST Accel, 2011 65
Table 58: Implantable Cardioverter Defibrillators, AnalyST, 2011 65
Table 59: Implantable Cardioverter Defibrillators CardiaLen, 2011 66
Table 60: Implantable Cardioverter Defibrillators, Chronicle, 2011 66
Table 61: Implantable Cardioverter Defibrillators, Clinical trials of Chronicle ICD 67
Table 62: Implantable Cardioverter Defibrillators, Current Plus, 2011 68
Table 63: Implantable Cardioverter Defibrillators, ENERGEN, 2011 69
Table 64: Implantable Cardioverter Defibrillators, Fortify ICD, 2011 69
Table 65: Implantable Cardioverter Defibrillators, INCEPTA, 2011 70
Table 66: Implantable Cardioverter Defibrillators, Paradym DR, 2011 70
Table 67: Implantable Cardioverter Defibrillators, Paradym VR Model 8250, 2011 71
Table 68: Implantable Cardioverter Defibrillators, PUNCTUA, 2011 71
Table 69: Implantable Cardioverter Defibrillators, S-ICD, 2011 72
Table 70: Implantable Cardioverter Defibrillators, Clinical Trials of S-ICD 72
Table 71: Implantable Cardioverter Defibrillators, Unconditional MRI Compatible ICD, 2011 73
Table 72: Cardiac Resynchronization Therapy-Defibrillators , Pipeline Products, 2011 74
Table 73: Cardiac Resynchronization Therapy-Defibrillators , ENERGEN, 2011 75
Table 74: Cardiac Resynchronization Therapy-Defibrillators, INCEPTA, 2011 75
Table 75: Cardiac Resynchronization Therapy-Defibrillators, Quad Polar, 2011 76
Table 76: Cardiac Resynchronization Therapy-Defibrillators, Paradym RF 8770 SonR, 2011 76
Table 77: Cardioverter Resynchronization Therapy-Defibrillators, Clinical Trials of Paradym RF 8770 SonR 77
Table 78: Cardiac Resynchronization Therapy-Defibrillators, Paradym RF Platform, 2011 77
Table 79: Cardiac Resynchronization Therapy-Defibrillators, Platinium ICD-CRT-D, 2011 78
Table 80: Cardiac Resynchronization Therapy-Defibrillators, Promote Quadra, 2011 78
Table 81: Cardiac Resynchronization Therapy-Defibrillators, Clinical Trials of Promote Quadra 79
Table 82: Cardiac Resynchronization Therapy-Defibrillators, PUNCTUA, 2011 80
Table 83: Cardiac Resynchronization Therapy-Defibrillators, Unify Quadra, 2011 80
Table 84: Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillator Market, Deals Landscape 81

List of Figures

Figure 1: Types of Arrhythmia 12
Figure 2: Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy- Defibrillators Market, Global, Revenue ($bn), 2003-2010 15
Figure 3: Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators Market, Global, Revenue ($bn), 2010-2017 16
Figure 4: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, the US, Revenue ($bn), 2003-2010 24
Figure 5: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, the US, Revenue ($bn), 2010-2017 25
Figure 6: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillator Market, Canada, Revenue ($m), 2003-2010 26
Figure 7: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Canada, Revenue ($m), 2010-2017 27
Figure 8: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, the UK, Revenue ($m), 2003-2010 28
Figure 9: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, the UK, Revenue ($m), 2010-2017 29
Figure 10: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Germany, Revenue ($m), 2003-2010 30
Figure 11: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Germany, Revenue ($m), 2010-2017 31
Figure 12: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, France, Revenue ($m), 2003-2010 32
Figure 13: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, France, Revenue ($m), 2010-2017 33
Figure 14: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Italy, Revenue ($m), 2003-2010 34
Figure 15: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Italy, Revenue ($m), 2010-2017 35
Figure 16: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Spain, Revenue ($m), 2003-2010 36
Figure 17: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Spain, Revenue ($m), 2010-2017 37
Figure 18: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Japan, Revenue ($m), 2003-2010 38
Figure 19: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Japan, Revenue ($m), 2010-2017 39
Figure 20: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, China, Revenue ($m), 2003-2010 40
Figure 21: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, China, Revenue ($m), 2010-2017 41
Figure 22: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, India, Revenue ($m), 2003-2010 42
Figure 23: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, India, Revenue ($m), 2010-2017 43
Figure 24: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Australia, Revenue ($m), 2003-2010 44
Figure 25: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Australia, Revenue ($m), 2010-2017 45
Figure 26: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillator Market, Brazil, Revenue ($m), 2003-2010 46
Figure 27: Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Brazil, Revenue ($m), 2010-2017 47
Figure 28: Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators Market, Global, Company Share (%), 2010 48
Figure 29: Implantable Cardioverter Defibrillators, Pipeline Products by Development Stage, 2011 64
Figure 30: Cardiac Resynchronization Therapy-Defibrillators, Pipeline Products by Developmental Stage, 2011 74

Companies Mentioned
Medtronic, Inc
St Jude Medical, Inc
Boston Scientific Corporation
Biotronik
Sorin Group